Interactive Decision Support Tool for HCPs

Share

Program Content

Activities

  • Adjuvant Tx HER2 Negative EBC
    Adjuvant Therapy for HER2-Negative Early Breast Cancer: Interactive Decision Support Tool
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 22, 2024

    Expires: August 21, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner